Clinical Trials List
2022-10-01 - 2024-09-26
Phase II/III
Recruiting4
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Yi-Chang Liu 無
- Tsung-Jang Yeh 無
- Jeng-Shiun Du 無
- 莊哲明 無
- Hui-Ching Wang 無
- Shih-Feng Cho Division of Hematology & Oncology
- 高育青 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ching Yun Hsieh 無
- Ming-Yu Lien 無
- Wei-Ching Lin 無
- Che-Hung Lin 無
- Tzu-Ting Chen 無
- Ching-Chan Lin 無
- 鄭富銘 無
- 王秀慈 無
- Chi-Ching Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Chien Chou 無
- 柯紀綸 Division of General Internal Medicine
- HSIN-AN HOU 無
- Chieh-Lung Cheng 無
- - - 無
- CHENG-HONG TSAI Division of General Internal Medicine
- Chien-Chin Lin 無
- BANG-BIN CHEN Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 曹朝榮 Division of Hematology & Oncology
- 高婉真 無
- 林正耀 無
- 陳昭勳 無
- Shang-Wen Chen 無
- 陳彥勳 無
- 陳彥勳 CPI奇美醫療財團法人柳營奇美醫院 無
- 林建良 無
- 黃文聰 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
1 participants
-
Global
36 participants
